Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in Recurrent or Metastatic Head and Neck Cancer
NCT01469546Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jan 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in head and neck squamous cell carcinoma (HNSCC), sponsored by University of Michigan Rogel Cancer Center. Started Jan 2012; status: completed.
02
Drugs
axitinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01469546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469546.